|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 11, 2015) - BioMmune Technologies Inc. (the "Company") (TSX VENTURE:IMU), announces a non-brokered private placement of up to 2,000,000 units (each a "Unit") at a price of $0.30 per Unit for gross proceeds of up to $600,000. Each Unit will consist of one common share and one common share purchase warrant (each a "Warrant"). Each Warrant entitles the holder to purchase one additional common share of the Company at a price of $0.40 per share for a period of 24 months from the date of closing, subject to an exercise acceleration clause. Under the exercise acceleration clause, which the Company may exercise once the Units are free of resale restrictions and if the Company's shares are trading at or above a volume weighted average price of $0.60 for 10 consecutive trading days, the Warrants will expire upon 30 days from the date the Company provides notice in writing to the Warrant holders via a news release. |
